AstraZeneca PLC
EURO STOXX 600Last update: May 9, 2026 at 09:32
Dividend Safety Rating
AZN.L's dividend appears safe and well-supported. Strengths include a 47.7% earnings payout ratio & 42.4% cfo payout ratio. Areas of concern: 0.9x current ratio & Volatile profit margin stability.
Based on 15 of 15 metrics
Strengths
- Earnings Payout Ratio: 47.7%Low earnings payout ratio leaves room to grow the dividend.
- Return on Equity: 23.5%Strong return on equity reflects efficient profit generation.
- Operating Margin: 28.2%Healthy operating margin provides a wide buffer.
Risks
- Current Ratio: 0.9xLimited short-term liquidity to meet obligations.
- Profit Margin Stability: VolatileProfit margins have been volatile.
Payout & Coverage
SafeBalance Sheet
CautionProfitability
SafeDividend Track Record
Very SafeAbout AstraZeneca PLC
AstraZeneca PLC is a multinational pharmaceutical and biotechnology company headquartered at the Cambridge Biomedical Campus in Cambridge, United Kingdom. It focuses on researching, developing, manufacturing, and commercializing innovative medicines and vaccines across key therapeutic areas including oncology, biopharmaceuticals, cardiovascular, renal, metabolism, respiratory, immunology, rare diseases, and infection. The company maintains major research and development centers in Cambridge, UK; Gaithersburg, Maryland, US; Gothenburg, Sweden; and Warsaw, Poland, supporting a pipeline that addresses cancer, cardiovascular diseases, kidney diseases, influenza, and other conditions. AstraZeneca PLC delivers products for primary care, specialty care, and global health initiatives, with operations spanning innovative medicines and biologics. Its portfolio emphasizes treatments for respiratory inflammation, autoimmune disorders, gastrointestinal issues, neuroscience, and vaccines, contributing to advancements in non-communicable diseases and access programs in various regions worldwide. Founded in 1999, AstraZeneca PLC plays a significant role in the global biopharmaceutical market through its comprehensive therapeutic focus and strategic R&D investments.
Dividend Overview
Dividend Yield
1.77%
Annual Dividend
£2.36
Frequency
Semi-Annual
Payout Ratio
47.70%
FCF Payout Ratio
63.39%
Stock Price
£133.60
52-Week Range
£96.51 – £157.32
Dividend History (2016–2025)
AZN.L annual dividend per share and yield history
Earnings & Profitability
AZN.L earnings per share and net profit margin
Key Dates
Last Ex-Dividend Date
February 19, 2026
Next Payment Date
—
Dividend Growth
3-Year Dividend CAGR
3.34%
5-Year Dividend CAGR
2.53%
10-Year Dividend CAGR
6.95%
3-Year Total Growth
10.37%
5-Year Total Growth
13.29%
10-Year Total Growth
95.76%
Income Calculator
Similar Dividend Stocks
Frequently Asked Questions
What is AZN.L's current dividend yield?
When is AZN.L's next dividend payment date?
How much does AZN.L pay in dividends per year?
Has AZN.L been increasing its dividend?
Is AZN.L's dividend safe?
How is AZN.L's Dividend Safety Rating calculated?
Want to understand how we rate dividend safety? Read our full methodology
Track AZN.L Dividends with OnlyDividends
What will AZN.L actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.
This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.
Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Safety Rating, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.
Market data provided by Twelve Data.